Filtered By:
Management: Partnerships
This page shows you your search results in order of date. This is page number 12.
Order by Relevance | Date
Total 424 results found since Jan 2013.
Advanced Cancer Diagnostics Reduce Frequency of Misdiagnoses: Interview with Precipio CEO Ilan Danieli
According to 2010-2012 data from the National Cancer Institute (NCI), 40% of men and women will be diagnosed with cancer in their lifetime. In all its forms, cancer is known to be a clinically and emotionally challenging disease to manage. Despite th...
Source: Medgadget - May 18, 2018 Category: Medical Devices Authors: Michael Batista Tags: Diagnostics Exclusive Oncology Pathology Source Type: blogs
Exclusive: BeCare Link ’s Innovative App for Multiple Sclerosis Patients
BeCare Link has created a mobile application (“BeCare MS Link” in the Google Play app store) that connects patients to physicians and researchers to provide unprecedented levels of insight into multiple sclerosis (MS) and other neurodegenerativ...
Source: Medgadget - May 10, 2018 Category: Medical Devices Authors: Alice Ferng Tags: Exclusive Medicine Neurology Rehab Source Type: blogs
How to talk to your doctor about medication
Pharmacology has changed the practice of medicine. Scientists are continually working on new and better drugs to manage medical conditions, from high blood pressure to autoimmune diseases to cancer. The mechanism of a drug — how it actually works on the condition it is mean to treat — is one important factor, but drug delivery, meaning how the medication arrives at the target it is meant to affect, is also key.
As a patient, it’s your right to understand everything about a medication prescribed for you. That doesn’t mean you have to become a scientist or pass an exam about pharmacology. But you can and should ask y...
Source: Harvard Health Blog - April 23, 2018 Category: Consumer Health News Authors: Carolyn A. Bernstein, MD, FAHS Tags: Drugs and Supplements Health Health care Source Type: blogs
Patient-Reported Outcome Measures: Progress Across the Pond
By TIM WILLIAMS & DAVID INTROCASO
This past October CMS Administrator Seema Verma announced the agency’s “Meaningful Measures” initiative.[1] Ms. Verma launched the initiative because, she admitted, the agency’s current quality measurement programming, widely criticized for years by MedPAC and others, ran the risk of outweighing the benefits. Under “Meaningful Measures,” CMS will, Ms. Verma stated, put “patients first” by aligning a smaller number of outcome-based quality measures meaningful to patients across Medicare’s programs. Since “the primary focus of a patient visit,” Ms. Verma...
Source: The Health Care Blog - April 19, 2018 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Source Type: blogs
Interview with Ori Geva, CEO of Medial EarlySign: A Healthcare Data Analytics Startup
Predictive analytics is the practice of learning from historical data in contemplation of making decisions about the future. Predictive analytics is not new to healthcare. However, in the past it has been limited by many factors, including data avail...
Source: Medgadget - March 22, 2018 Category: Medical Devices Authors: Kenan Raddawi Tags: Exclusive Informatics Medicine Public Health Source Type: blogs
How Would One Go About Building a Company to Bring Cheap Senolytics to the World?
Let us for a moment choose to believe that the dasatinib and quercetin combination is a senolytic treatment that does as well in humans as it does in mice. This is to say it kills about 25-50% of senescent cells in the tissues usually most affected by oral medications, meaning the kidney, liver, and cardiovascular system, and some unknown but lower fraction elsewhere. Whether or not this is the case has yet to be determined; the first pilot studies are still running at Betterhumans, and they likely won't tell us the size of the effect in terms of fraction of cells removed. Viable assays for cellular senescence that can be ...
Source: Fight Aging! - February 21, 2018 Category: Research Authors: Reason Tags: Activism, Advocacy and Education Source Type: blogs
Inspirata Acquires Omnyx from GE Healthcare, Achieving an End-to-End Solution
The business model of Inspirata is relatively unique compared to other companies connected to digital pathology. The company seeks to enhance the digital pathology workflow of its clients presumably pathology departments and consulting firms. Here is a summary of the company goals copied from the company web page (WELCOME TO INSPIRATA):We...help cancer institutions overcome the financial barriers to adoption using our unique business and delivery model where we make the upfront capital investment in the hardware, software and storage needed to enable a cancer institution to move to a fully automated digital pathology...
Source: Lab Soft News - February 7, 2018 Category: Laboratory Medicine Authors: Bruce Friedman Tags: Digital Imaging in Pathology Food and Drug Administration Lab Industry Trends Lab Processes and Procedures Lab Regulation Pathology Informatics Surgical Pathology Source Type: blogs
Think critically about for-profit donor entities and their commitments to health
At my job as a primary care doctor in a federal safety net clinic, I was given a free T-shirt to wear the following day. It reads “Crucial Catch — Intercept Cancer” in between the logos of the National Football League (NFL) and the American Cancer Society (ACS). This celebrates the 8-year partnership of almost $18 million dollars donated to fund cancer screening and prevention. These philanthropic gestures of large donors help to fund valuable projects and raise visibility, as demonstrated by my entire clinic staff getting ready to sport their campaign gear. However, recent history of the NFL delineates ...
Source: Kevin, M.D. - Medical Weblog - February 2, 2018 Category: General Medicine Authors: < a href="https://www.kevinmd.com/blog/post-author/emi-okamoto" rel="tag" > Emi Okamoto, MD < /a > Tags: Physician Cardiology Neurology Source Type: blogs
The UPMC-Highmark Brawl Spills Into Philadelphia ’ s Backyard
By TORY WOLFF
The UPMC/Highmark rivalry continues to open new fronts in Pennsylvania. Highmark’s response to UPMC is differentiated in two ways: first, Highmark is using a coalition-building strategy and, second, it is controlling its exposure to big in-patient assets; in contrast, UPMC is building an integrated, single-brand system and happily taking over hospitals (and building more) along the way. When UPMC and Highmark make major investments in a region, local systems will be caught in the capex arms and feel the pressure to affiliate. Credibly threatening to respond in kind may defuse the arms race. But unaffiliated...
Source: The Health Care Blog - January 22, 2018 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Highmark UPMC Source Type: blogs
Matthew Holt ’ s EOY 2017 letter (charities/issues/gossip)
Right at the end of every year I write a letter summarizing my issues and charities. And as I own the joint here, I post it on THCB! Please take a look–Matthew Holt
Well 2017 has been quite a year, and last year 2016 I failed to get my end-of-year letter out at all. This I would like to think was due to extreme business but it probably came down to me being totally lazy. On the other hand like many of you I may have just been depressed about the election–2016 was summed up by our cat vomiting on our bed at 11.55 on New Years Eve.
Having said that even though most of you will never comment on this letter and I ...
Source: The Health Care Blog - December 31, 2017 Category: Consumer Health News Authors: Matthew Holt Tags: Matthew Holt Charity Patient Activism Source Type: blogs
BioViva Illustrates the Tension Between Progress and Regulation
Elizabeth Parrish of BioViva, you might recall, has made every effort to publicize the follistatin and telomerase gene therapy that she underwent. This is a strategy intended to accelerate progress; I suspect she was not the first, and that others were just more circumspect. The technology exists, it is not expensive in the grand scheme of things, and at the very least hundreds of people have the laboratory access and the knowledge to carry out such an operation. BioViva's efforts, and those of other ventures such as the Odin and Ascendance Biomedical illustrate the tension between desire for progress and desire for regula...
Source: Fight Aging! - December 27, 2017 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
The Young Adult Ignored Cancer Patients
This is one of my pet peeves. Children with cancer have their mature, sane parents advocating for them. Adults with cancer can advocate for themselves.The young adults - 15 to 30s - often don ' t find the same support or resources. First they are still trying to figure out who they are and what they will do with their life. Second, they are learning to be independent and should be focusing on their education and careers, not going to chemotherapy. There is hope now that online resources can help fill the gaps for the patients and maybe for the doctors as well." In addition, they will probably go on to live long lives and t...
Source: Caroline's Breast Cancer Blog - December 22, 2017 Category: Cancer & Oncology Tags: cancer bonds cancer treatment side effects young cancer patients Source Type: blogs
Exponential Medicine 2017 Day 1 & 2 Conference Overview: Virtual Reality, Transcriptomics, and an Exciting Announcement by the ACS
Welcome to Medgadget’s overview of this year’s Exponential Medicine (ExMed) conference by Singularity University (SU), which took place, for its fifth year in a row, in San Diego, CA at the Hotel Del Coronado last month. This year ExMed ...
Source: Medgadget - December 21, 2017 Category: Medical Devices Authors: Michael Batista Tags: Exclusive Medicine Source Type: blogs
PhRMA Releases New Policy Proposals
On December 11, 2017, the Pharmaceutical Research and Manufacturers of America (PhRMA) issued statements of support for several policy proposals focused on resolving the opioid crisis. The proposals included: limits on prescribing, a ban on prescribing of Schedule II opioids in an office setting, ongoing prescriber training, and expanded access to addiction treatment options.
Along with the policy proposals came an announcement that PhRMA and the Addiction Policy Forum have entered into a multi-year, multi-million dollar initiative to combat the opioid crisis and implement the Forum's plan to help solve the opioid crisis....
Source: Policy and Medicine - December 21, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs
Fighting Over Money? How to Stop Arguing About Finances
Money can be a loaded topic, especially during the holidays or when business, family, and finances mix. It’s one of the biggest sources of relationship problems — and it can be the toughest to resolve.
Throughout the course of any partnership, butting heads over spending and saving habits is to be expected. Couples can face financial rough patches that are more emotionally complex than deciding whether to splurge on take-out this week. When this happens, it can feel overwhelming and affect your ability to focus at work and home.
That’s because money fights are rarely about dollars and cents. They’re usually a...
Source: World of Psychology - December 17, 2017 Category: Psychiatry & Psychology Authors: Melody Wilding, LMSW Tags: Agitation Anger Caregivers Family General Marriage and Divorce Money and Financial Relationships Self-Help Stress Success & Achievement Women's Issues arguments Finances financial trouble Marital Conflict Money Problems s Source Type: blogs
